Bone marrow lymphoid aggregates in myelodysplastic syndromes: incidence, immunomorphological characteristics and correlation with clinical features and survival-Reference-Cited by-同舟云学术

Bone marrow lymphoid aggregates in myelodysplastic syndromes: incidence, immunomorphological characteristics and correlation with clinical features and survival

Published:2002-06 Issue:6 Volume:26 Page:525-530
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Magalhães Silvia M.M.,Filho F.Dário Rocha,Vassallo José,Pinheiro Mariana P.,Metze Konradin,Lorand-Metze Irene

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference32 articles.

1. Lymphoid nodules and nodular lymphoid hyperplasia in bone marrow biopsies;Navone;Acta. Haematol.,1985

2. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma—a practical guideline;Thiele;J. Clin. Pathol.,1999

3. Incidence and characteristics of lymphoid malignancies in untreated myelodysplastic syndromes;Florensa;Leuk. Lymphoma,1996

4. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies;Mangi;Blood.,1992

5. Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors;Rios;Br. J. Haematol.,1990

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathologic correlates and prognostic impact of lymphoid aggregates in patients with myelodysplastic syndromes;British Journal of Haematology;2024-07-31

2. Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes – A potential prognostic marker?;Frontiers in Oncology;2023-01-26

3. Lymphoid aggregates in bone marrow: a diagnostic pitfall;Journal of Clinical Pathology;2022-09-23

4. Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine;Journal of Clinical Medicine;2021-10-20

5. Histopathology in the diagnosis of high-risk myelodysplastic syndromes;Journal of Clinical and Experimental Hematopathology;2018